Mary Ocnean, Vice President of ImpriMed, will host lunch webinars to introduce ImpriMed's Personalized Prediction Profile and discuss how ImpriMed can help you create an effective treatment plan for hematopoietic cancer patients.
Ask any questions during the webinar!
Lunch will be provided for all oncology team members
Mary Ocnean
Collin H. Cavanaugh
We focus on providing accurate information, actionable insights and a comprehensive personalized care plan.
Whether you want to use combination therapy or a single agent, our tests allow you to focus on the best course of treatment for each specific patient.
Once you fill out the form, we will reach out to you via email.
Select a date & time below to schedule a virtual team lunch directly here.